Opportunities for Collaborative Research at the NIH Clinical Center
ID: 359659Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359659
Timeline
    Description

    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Opportunities for Collaborative Research at the NIH Clinical Center," aimed at supporting collaborative translational research projects that enhance the application of basic biological discoveries to clinical settings. This program encourages partnerships between NIH intramural investigators and extramural researchers to accelerate patient-centric translational research, focusing on understanding disease processes and developing new therapeutic interventions, diagnostics, or prevention strategies. Interested small businesses can apply for this cooperative agreement, with no cost-sharing requirement, and should note that the estimated synopsis post date is September 1, 2025, with a closing date of December 12, 2025. For further inquiries, applicants can contact Dr. David J. Eckstein at 301-496-4121 or via email at ClinicalCtrPartner@mail.nih.gov.

    Point(s) of Contact
    David J. Eckstein, PhD NIH Office of Clinical Research Education and Collaboration Outreach (OD)
    (301) 496-4121
    ClinicalCtrPartner@mail.nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Core Centers for Clinical Research (CCCR)" aimed at advancing methodological sciences in clinical research related to musculoskeletal, rheumatic, and skin diseases. This initiative seeks to establish centers that will focus on the prevention, diagnosis, and treatment of these conditions, emphasizing the development of novel methods and metrics while ensuring community representation throughout the research process. Eligible applicants include small businesses, with no cost-sharing or matching requirements, and the estimated project start date is set for July 1, 2027. Interested parties can reach out to Dr. Melissa C. Green Parker at melissa.greenparker@nih.gov or by phone at 240-755-3031 for further information, with the application period expected to close on September 25, 2026.
    NIAID Clinical Trial Implementation Cooperative Agreement
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIAID Clinical Trial Implementation Cooperative Agreement, aimed at supporting high-risk clinical trials and associated mechanistic studies. This program invites small businesses to submit applications for cooperative agreements that facilitate the implementation, conduct, and analysis of investigator-initiated clinical trials, including activities such as training personnel, recruiting subjects, and managing data. The initiative is crucial for advancing research in health-related fields, with no cost-sharing requirements, and is governed by specific federal regulations. Interested applicants can reach out to Dr. Cynthia de la Fuente at cynthia.delafuente@nih.gov or call 240-699-2740 for further information. The estimated synopsis post date is December 5, 2025, with a closing date for applications on February 25, 2026, and an anticipated award date of December 1, 2026.
    NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA), is inviting eligible United States small business concerns (SBCs) to prepare for the upcoming Small Business Innovation Research (SBIR) Grant opportunity, specifically under the Parent SBIR [R43/R44] Clinical Trial Not Allowed category. This funding opportunity aims to support innovative research and development projects that align with the missions of the NIH, CDC, and FDA, encouraging collaborations among small businesses with relevant technological expertise. While applications are not currently being solicited, potential applicants should note that the estimated synopsis post date is October 1, 2025, with a closing date of January 5, 2026, and an estimated award date of June 1, 2026. For further inquiries, interested parties can contact the NIH SEED Office at SEEDinfo@nih.gov or by phone at 301-827-8595.
    NIAID Resource-Related Research Projects
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "NIAID Resource-Related Research Projects," aimed at supporting investigator-initiated research that develops essential resources for biomedical research. This program encourages small businesses to propose non-hypothesis-driven activities that provide high-quality data, materials, tools, or services relevant to the NIAID mission, which includes areas such as infectious diseases, immune function, and translational research for vaccines and therapeutics. Interested applicants should note that there is no cost-sharing requirement, and the estimated synopsis close date is January 26, 2026, with awards expected to be made by December 1, 2026. For further inquiries, applicants can contact Dr. Chelsea Boyd at chelsea.boyd@nih.gov or by phone at 301-761-6664.
    Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)" aimed at supporting research that leverages resources from ongoing clinical studies. This initiative encourages applications for ancillary studies that align with the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), utilizing well-characterized patient cohorts, infrastructure, data, and biological samples from parent studies. With an estimated total program funding of $2 million and an expected four awards, interested small businesses are encouraged to collaborate and develop responsive projects. Key deadlines include an estimated synopsis post date of February 4, 2026, a close date of April 6, 2026, and an anticipated award date of December 4, 2026. For further inquiries, applicants can contact Heiyoung Park, Ph.D., at Heiyoung.Park@nih.gov or by phone at 301-827-5992.
    NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (FON PAR-24-099) aimed at small business concerns proposing investigator-initiated clinical trials that align with the NIAID's research mission. This program supports hypothesis-driven and milestone-driven clinical trials, particularly those classified as high-risk, which may involve unique interventions or the use of licensed products for unapproved indications. The initiative underscores the government's commitment to advancing innovative clinical research to address significant healthcare challenges, with funding of up to $1 million annually available for meritorious applications. Interested applicants must adhere to strict guidelines and submit their applications by the various deadlines, with the first due date on April 12, 2024, and the final deadline on January 13, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the R61/R33 grant program, aimed at supporting investigator-initiated single-site clinical trials. This initiative encourages applications that focus on various types of clinical trials, including efficacy, comparative effectiveness, and implementation research, particularly those employing innovative trial designs such as adaptive and Bayesian methods. The trials must align with the research mission of the National Heart, Lung, and Blood Institute (NHLBI) and adhere to the NIH definition of a clinical trial. Interested small businesses are advised to begin developing collaborative projects in anticipation of the application period, which is expected to open following the estimated synopsis post date of July 11, 2025, with applications due by October 13, 2025. For further inquiries, potential applicants can contact Dr. Yves Rosenberg at rosenbey@nhlbi.nih.gov or by phone at 301-435-1292.
    NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Clinical Research Center Grant (P50 Clinical Trial Optional) aimed at advancing research in the areas of hearing, balance, smell, taste, voice, speech, or language. This grant encourages small businesses to form multidisciplinary teams that will collaborate on a synergistic set of 3-4 research projects addressing a unifying theme related to sensory and communication disorders. The initiative is designed to foster innovative solutions to complex clinical problems through integrated research efforts, supported by an administrative core and optional scientific cores. Interested applicants should note that while applications are not currently being solicited, they are encouraged to prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of August 6, 2025, and a close date of October 7, 2025. For further inquiries, potential applicants can contact Holly Storkel, Ph.D., at holly.storkel@nih.gov or by phone at 301-496-5061.
    NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering a Small Business Innovation Research (SBIR) Grant opportunity for United States small business concerns (SBCs) to submit applications for various phases of research and development, including Phase I, Phase II, Direct to Phase II, Fast-Track, and Phase IIB grants. Eligible applicants must possess the necessary research capabilities and technological expertise to support the R&D missions of the NIH and CDC, with a focus on health-related innovations. This funding opportunity is significant as it encourages collaboration among small businesses to advance health research, with applications expected to be solicited following the reauthorization of the SBIR program. Interested parties can reach out to the NIH SEED Office at SEEDinfo@nih.gov or call 301-827-8595 for further information, with the estimated synopsis posting date set for October 1, 2025, and a closing date for applications anticipated on January 5, 2026.
    Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to solicit applications for the establishment of a Clinical Coordinating Center (CCC) dedicated to multi-site investigator-initiated clinical trials, including efficacy, comparative effectiveness, and implementation research. The objective of this opportunity is to develop a comprehensive scientific and operational plan for the clinical trials that align with the research mission of the National Heart, Lung, and Blood Institute (NHLBI) and meet the NIH definition of a clinical trial. This cooperative agreement will follow a bi-phasic, milestone-driven award mechanism and requires the submission of both a CCC application and a collaborating Data Coordinating Center (DCC) application by the same deadline. Interested applicants can reach out to Dr. Yves Rosenberg at rosenbey@nhlbi.nih.gov or call 301-435-0550 for further information. The estimated synopsis post date is July 11, 2025, with applications expected to close on October 13, 2025, and awards anticipated by May 1, 2026.